4//SEC Filing
Lam Karen C 4
Accession 0001593968-20-002125
CIK 0001673772other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:29 PM ET
Size
5.3 KB
Accession
0001593968-20-002125
Insider Transaction Report
Form 4
Lam Karen C
VP, Finance & Controller
Transactions
- Sale
Common Stock
2020-11-02$28.14/sh−2,022$56,899→ 12,735 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.09 to $29.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Includes 2,022 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on October 30, 2020.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001783296
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 8:29 PM ET
- Size
- 5.3 KB